Citadel Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $206M | Buy |
1,481,200
+350,700
| +31% | +$49.1M | 0.03% | 444 |
|
|
2025
Q4 | $139M | Sell |
1,130,500
-16,300
| -1% | -$1.98M | 0.02% | 670 |
|
|
2025
Q3 | $127M | Sell |
1,146,800
-399,800
| -26% | -$45.4M | 0.02% | 692 |
|
|
2025
Q2 | $171M | Buy |
1,546,600
+312,900
| +25% | +$33.3M | 0.03% | 471 |
|
|
2025
Q1 | $138M | Buy |
1,233,700
+464,500
| +60% | +$47.9M | 0.03% | 521 |
|
|
2024
Q4 | $71.1M | Sell |
769,200
-540,200
| -41% | -$48.6M | 0.01% | 982 |
|
|
2024
Q3 | $110M | Buy |
1,309,400
+165,700
| +14% | +$12.6M | 0.02% | 647 |
|
|
2024
Q2 | $78.5M | Buy |
1,143,700
+258,400
| +29% | +$17.2M | 0.02% | 824 |
|
|
2024
Q1 | $64.8M | Sell |
885,300
-161,000
| -15% | -$12.4M | 0.01% | 1016 |
|
|
2023
Q4 | $84.8M | Sell |
1,046,300
-381,000
| -27% | -$29.6M | 0.02% | 787 |
|
|
2023
Q3 | $107M | Sell |
1,427,300
-153,100
| -10% | -$11.8M | 0.02% | 602 |
|
|
2023
Q2 | $122M | Buy |
1,580,400
+124,300
| +9% | +$9.91M | 0.03% | 514 |
|
|
2023
Q1 | $121M | Sell |
1,456,100
-688,900
| -32% | -$57.1M | 0.03% | 533 |
|
|
2022
Q4 | $184M | Sell |
2,145,000
-644,500
| -23% | -$51M | 0.04% | 362 |
|
|
2022
Q3 | $172M | Sell |
2,789,500
-786,500
| -22% | -$49.6M | 0.04% | 369 |
|
|
2022
Q2 | $221M | Sell |
3,576,000
-546,900
| -13% | -$33.9M | 0.06% | 249 |
|
|
2022
Q1 | $245M | Buy |
4,122,900
+1,137,100
| +38% | +$72.7M | 0.05% | 268 |
|
|
2021
Q4 | $217M | Buy |
2,985,800
+282,200
| +10% | +$19.4M | 0.04% | 315 |
|
|
2021
Q3 | $189M | Sell |
2,703,600
-270,100
| -9% | -$19M | 0.04% | 363 |
|
|
2021
Q2 | $205M | Buy |
2,973,700
+816,300
| +38% | +$54.5M | 0.05% | 309 |
|
|
2021
Q1 | $139M | Buy |
2,157,400
+364,700
| +20% | +$23.5M | 0.03% | 435 |
|
|
2020
Q4 | $104M | Sell |
1,792,700
-1,050,300
| -37% | -$63.4M | 0.03% | 524 |
|
|
2020
Q3 | $180M | Buy |
2,843,000
+205,000
| +8% | +$14.2M | 0.05% | 230 |
|
|
2020
Q2 | $203M | Buy |
2,638,000
+232,100
| +10% | +$17.8M | 0.07% | 179 |
|
|
2020
Q1 | $180M | Buy |
2,405,900
+151,200
| +7% | +$10.4M | 0.08% | 160 |
|
|
2019
Q4 | $147M | Buy |
2,254,700
+761,400
| +51% | +$49.6M | 0.06% | 263 |
|
|
2019
Q3 | $94.6M | Sell |
1,493,300
-536,600
| -26% | -$35.1M | 0.04% | 423 |
|
|
2019
Q2 | $137M | Buy |
2,029,900
+354,400
| +21% | +$23.3M | 0.06% | 272 |
|
|
2019
Q1 | $109M | Sell |
1,675,500
-1,024,300
| -38% | -$68.1M | 0.05% | 332 |
|
|
2018
Q4 | $169M | Buy |
2,699,800
+1,083,700
| +67% | +$75.7M | 0.09% | 160 |
|
|
2018
Q3 | $125M | Sell |
1,616,100
-335,800
| -17% | -$25.4M | 0.06% | 330 |
|
|
2018
Q2 | $138M | Buy |
1,951,900
+258,900
| +15% | +$18.3M | 0.07% | 265 |
|
|
2018
Q1 | $128M | Sell |
1,693,000
-23,800
| -1% | -$1.89M | 0.07% | 235 |
|
|
2017
Q4 | $123M | Sell |
1,716,800
-199,300
| -10% | -$15.1M | 0.07% | 261 |
|
|
2017
Q3 | $155M | Sell |
1,916,100
-287,000
| -13% | -$21.9M | 0.12% | 135 |
|
|
2017
Q2 | $156M | Buy |
2,203,100
+762,000
| +53% | +$50.7M | 0.13% | 120 |
|
|
2017
Q1 | $97.9M | Sell |
1,441,100
-241,700
| -14% | -$17M | 0.09% | 208 |
|
|
2016
Q4 | $121M | Buy |
1,682,800
+207,900
| +14% | +$15.5M | 0.12% | 125 |
|
|
2016
Q3 | $117M | Buy |
1,474,900
+98,500
| +7% | +$8M | 0.12% | 129 |
|
|
2016
Q2 | $115M | Buy |
1,376,400
+176,900
| +15% | +$15.7M | 0.13% | 120 |
|
|
2016
Q1 | $110M | Buy |
1,199,500
+472,400
| +65% | +$42.6M | 0.14% | 107 |
|
|
2015
Q4 | $73.6M | Sell |
727,100
-224,200
| -24% | -$23.3M | 0.08% | 267 |
|
|
2015
Q3 | $93.4M | Buy |
951,300
+105,500
| +12% | +$11.7M | 0.09% | 224 |
|
|
2015
Q2 | $99M | Buy |
845,800
+544,400
| +181% | +$59.5M | 0.09% | 239 |
|
|
2015
Q1 | $29.6M | Sell |
301,400
-166,300
| -36% | -$16.9M | 0.03% | 758 |
|
|
2014
Q4 | $44.1M | Sell |
467,700
-215,100
| -32% | -$22.2M | 0.04% | 531 |
|
|
2014
Q3 | $72.7M | Buy |
682,800
+64,300
| +10% | +$6.3M | 0.08% | 267 |
|
|
2014
Q2 | $51.3M | Sell |
618,500
-224,500
| -27% | -$17.5M | 0.06% | 359 |
|
|
2014
Q1 | $59.7M | Buy |
843,000
+201,900
| +31% | +$15.8M | 0.07% | 333 |
|
|
2013
Q4 | $48.2M | Sell |
641,100
-26,500
| -4% | -$1.85M | 0.06% | 373 |
|
|
2013
Q3 | $42M | Buy |
667,600
+168,600
| +34% | +$10.1M | 0.06% | 381 |
|
|
2013
Q2 | $25.6M | Buy |
+499,000
| New | +$26M | 0.04% | 528 |
|
Other funds holding GILD
VCM
VPM
Citadel Advisors's GILD Position: Q1 2026 in Review
Citadel Advisors increased its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, buying an estimated $13.3M and bringing the position to 3,982,185 shares worth $555M. The position accounts for 0.09% of the portfolio, ranked #156.
Citadel Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $607M in Q2 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Citadel Advisors held 3,982,185 shares of Gilead Sciences worth $555M as of Q1 2026.
- Citadel Advisors bought 94,665 Gilead Sciences shares in Q1 2026, an estimated $13.3M.
- Gilead Sciences made up 0.09% of Citadel Advisors's portfolio in Q1 2026, its #156 holding.
- Citadel Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Gilead Sciences position peaked at $607M in Q2 2025.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.